Geraldine Blanchard-Rohner

University Hospital of Geneva

Research Interests

Explore related searches

Contact this professor

Google Scholar

Articles (26)

Collaborators (14)

Fabio Candotti

Full Professor of Medicine

Lausanne University Hospital

Ann Gardulf

Karolinska Institutet

Jana Pachlopnik Schmid

University of Zurich

Raphael Johannes Scheible

Klinikum rechts der Isar der Technischen Universität München

Carlos Sanchez

University Children’s Hospital Basel

Petra Zimmermann

Daniel Drozdov

University of Minnesota

UNITED STATES

Janine Reichenbach

Head Division of Somatic Gene Therapy

University Children's Hospital Zurich

Rachael Philips

National Institutes of Health

UNITED STATES

Manolis Pasparakis

University of Cologne

Jürg Hammer

Head / Prof. Dr. med.

University Children's Hospital Zurich

Mana Momenilandi

Imagine Institute for Genetic Diseases

Michael Buettcher

Klinischer Dozent - University Lecturer

University of Lucerne

Markus G Seidel

Professor of Translational Pediatric Hematology and Immunology

Medical University of Graz

Geraldine Blanchard-Rohner

Research Interests

Explore related searches

Contact this professor

Articles (26)

Vaccine Immunity Against Pneumococcus in Children With Cochlear Implants

Vaccine Immunity Against Pneumococcus in Children With Sickle Cell Disease: A Retrospective Single-center Study

Well-Being of Children and Adolescents with and without Special Healthcare Needs Following the Lifting of Pandemic-Related Restrictions.

Reply to Hinpetch Daungsupawong

[Autoimmune diseases of the central nervous system in children : Efficacy or immaturity of the immune system?]

[What is new in pediatric rheumatological diseases?]

Vaccine immunity in patients with 22q11.2 microdeletion syndrome

Clinical efficacy of SARS‐CoV‐2 Omicron‐neutralizing antibodies in immunoglobulin preparations for the treatment of agammaglobulinemia in patients with primary antibody deficiency

Assessing vaccine-induced immunity against pneumococcus, hepatitis A and B over a 9-year follow-up in pediatric liver transplant recipients: A nationwide retrospective study

One-year Longitudinal Study of Antibody Profiles in Children: MIS-C Versus Children With Uncomplicated COVID-19

Rituximab‐to‐vaccine interval on SARS‐CoV‐2 immunogenicity in children: The potential role of prior natural infection

COVID-19 Vaccine Acceptance Among Parents of Children With Multisystem Inflammatory Syndrome in Children

Aktuelles aus der pädiatrischen Immunologie: Erfolge bei der Erkennung neuer Immundefekte im Neugeborenen-Screening

Vaccine Immunity in Children After Hematologic Cancer Treatment: A Retrospective Single-center Study

Incontinentia pigmenti underlies thymic dysplasia, autoantibodies to type I IFNs, and viral diseases.

Hyper‐IgE syndrome presenting with early life craniosynostosis in monozygotic twin sisters

Human germline heterozygous gain-of-function STAT6 variants cause severe allergic disease.

Methylprednisolone versus intravenous immunoglobulins in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS): an open-label, multicentre, randomised trial.

[Which immunological pathologies are targeted by precision medicine?]

Autoantibodies to a Nodal Isoform of Neurofascin in Pediatric Chronic Inflammatory Demyelinating Polyneuropathy.

Nouveautés en immunologie pédiatrique : Succès du dépistage néonatal et nouveaux déficits immunitaires

Novel approaches to reactivate pertussis immunity.

Lorsque derrière une thrombocytopénie, une sarcoïdose présumée, une fièvre récidivante ou une lymphadénopathie se cache un déficit immunitaire congénital

Wenn hinter einer Immunthrombozytopenie, einer vermeintlichen Sarkoidose, rezidivierendem Fieber oder einer Lymphadenopathie ein angeborener Immundefekt steckt

Evaluation of rotavirus vaccine administration among a 22q11.2DS patient population.

Multicenter Randomized Trial of Methylprednisolone vs. Intravenous Immunoglobulins to Treat the Pediatric Inflammatory Multisystem Syndrome-Temporally Associated With SARS-CoV-2 (PIMS-TS): Protocol of the Swissped RECOVERY Trial.